Harnessing AI and Imaging Innovations for Enhanced Detection and Diagnosis of Age-Related Macular Degeneration: An In-Depth Review

Age-related macular degeneration (AMD) is a leading cause of irreversible vision impairment among the elderly population worldwide, affecting over 196 million people globally. This study delves into innovative approaches for improving the detection and management of AMD through advanced technological solutions. To investigate the impact of ultraviolet (UV) and blue light exposure on AMD, the research analyzes their contribution to oxidative stress and retinal damage and evaluates potential protective measures or interventions to mitigate these effects. By leveraging state-of-the-art machine learning algorithms and advanced image processing techniques, the research aims to enhance the precision and efficiency of AMD diagnosis. The statistical burden of AMD underscores its significant impact on global health, with projections indicating a rising prevalence due to aging populations, lifestyle factors, and increasing digital screen use among younger generations. Effective management hinges on early detection and accurate monitoring of AMD biomarkers, which these methodologies seek to facilitate. Experimental evaluations demonstrate promising outcomes in diagnostic accuracy and scalability, highlighting the potential for widespread adoption in clinical practice. Furthermore, these advancements contribute to broader efforts in global eye health by offering scalable, AI-driven solutions that can improve patient outcomes and streamline healthcare workflows. By addressing the complexities of AMD diagnosis, this research supports healthcare providers in delivering timely interventions and personalized care, ultimately reducing the burden of AMD-related vision loss on individuals and healthcare systems.